LKY-047: First Selective Inhibitor of Cytochrome P450 2J2

Nguyen Minh Phuc; Zhexue Wu; Yuseok O; Jee-Hyun Lee; Sangtaek Oh; Gyu-Yong Song; Kwang-Hyeon Liu

doi:10.1124/dmd.117.075036

Rapid CommunicationShort Communication

LKY-047: First Selective Inhibitor of Cytochrome P450 2J2

Nguyen Minh Phuc, Zhexue Wu, Yuseok O, Jee-Hyun Lee, Sangtaek Oh, Gyu-Yong Song and Kwang-Hyeon Liu

Drug Metabolism and Disposition July 2017, 45 (7) 765-769; DOI: https://doi.org/10.1124/dmd.117.075036

Nguyen Minh Phuc

BK21 Plus KNU Multi-Omics-Based Creative Drug Research Team, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Korea (N.M.P., Z.W., K.-H.L.); College of Pharmacy, Chungnam National University, Daejeon, Korea (Y.O., J.-H.L., G.-Y.S.); and Department of Bio and Fermentation Convergence Technology, BK21 PLUS Program, Kookmin University, Seoul, Korea (S.O.)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zhexue Wu

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yuseok O

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jee-Hyun Lee

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sangtaek Oh

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gyu-Yong Song

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kwang-Hyeon Liu

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF + SI
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Drug Metabolism and Disposition

Vol. 45, Issue 7

1 Jul 2017

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following LKY-047: First Selective Inhibitor of Cytochrome P450 2J2

Message Subject (Your Name) has forwarded a page to you from Drug Metabolism & Disposition

Message Body (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.

Your Personal Message

Citation Tools

Rapid CommunicationShort Communication